Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? (2022)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.12998/wjcc.v10.i4.1454
- Subjects: HIV; MIOPATIAS CONGÊNITAS ESTRUTURAIS; REUMATOLOGIA; TERAPÊUTICA
- Language: Inglês
- Imprenta:
- Publisher place: Pleasanton
- Date published: 2022
- Source:
- Título: World journal of clinical cases
- ISSN: 2307-8960
- Volume/Número/Paginação/Ano: v. 10, n. 4, p. 1454-1456, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GONCALVES JUNIOR, Jucier e SHINJO, Samuel Katsuyuki. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?. World journal of clinical cases, v. 10, n. 4, p. 1454-1456, 2022Tradução . . Disponível em: https://doi.org/10.12998/wjcc.v10.i4.1454. Acesso em: 13 fev. 2026. -
APA
Goncalves Junior, J., & Shinjo, S. K. (2022). Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? World journal of clinical cases, 10( 4), 1454-1456. doi:10.12998/wjcc.v10.i4.1454 -
NLM
Goncalves Junior J, Shinjo SK. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? [Internet]. World journal of clinical cases. 2022 ; 10( 4): 1454-1456.[citado 2026 fev. 13 ] Available from: https://doi.org/10.12998/wjcc.v10.i4.1454 -
Vancouver
Goncalves Junior J, Shinjo SK. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? [Internet]. World journal of clinical cases. 2022 ; 10( 4): 1454-1456.[citado 2026 fev. 13 ] Available from: https://doi.org/10.12998/wjcc.v10.i4.1454 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
Informações sobre o DOI: 10.12998/wjcc.v10.i4.1454 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
